Physician profile
Sari R Levine
NPI 1508814393
$2,692.46
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $882 · 2020: $387 · 2021: $647 · 2022: $582 · 2023: $171 · 2024: $23.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $258.21 | 2021-2022 | |
| Abbvie INC. | $250.71 | 2019-2022 | |
| Janssen Biotech, INC. | $204.67 | 2019-2022 | |
| Astellas Pharma US INC | $186.27 | 2019-2022 | |
| Agiliti Surgical, INC. | $151.32 | 2023 | Sonablate |
| Pfizer INC. | $134.43 | 2019-2020 | |
| Boston Scientific Corporation | $132.49 | 2019-2021 | |
| Myovant Sciences INC. | $127.51 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $98.66 | 2019-2022 | |
| 180 Medical, INC. | $93.73 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $86.59 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $86.39 | 2019 | |
| Therapeuticsmd, INC. | $83.65 | 2019-2021 | |
| Coloplast Corp | $81.94 | 2020-2022 | |
| Antares Pharma, INC. | $80.00 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $78.44 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $71.76 | 2021-2022 | |
| Amgen INC. | $68.32 | 2019-2022 | |
| Travere Therapeutics, INC. | $65.17 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.66 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $50.00 | 2019 | |
| Merck Sharp & Dohme LLC | $47.20 | 2021 | |
| Hollister Incorporated | $43.67 | 2020-2021 | |
| Axonics, INC. | $35.51 | 2021-2024 | Axonics |
| Laborie Medical Technologies Corp. | $25.03 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $22.53 | 2021 | |
| Procept Biorobotics Corporation | $21.89 | 2021 | |
| Medtronic, INC. | $20.00 | 2023 | Interstim |
| Blue Earth Diagnostics | $15.59 | 2021 | |
| Photocure INC | $15.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sari Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.